Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 6761549, 12 pages
https://doi.org/10.1155/2017/6761549
Research Article

Quantitative Serum Proteomic Analysis of Essential Hypertension Using iTRAQ Technique

1Shandong University of Traditional Chinese Medicine, 4655 Daxue Road, Changqing District, Jinan, Shandong Province, China
2Affiliated Hospital of Shandong University of Traditional Chinese Medicine, 16369 Jingshi Road, Lixia District, Jinan, Shandong Province, China
3Affiliated Hospital of Shandong Academy of Medical Sciences, 38 Shadowless Hill Road, Tianqiao District, Jinan, Shandong Province, China

Correspondence should be addressed to Yun-Lun Li; moc.liamtoh@eel.nulnuy

Received 5 April 2017; Accepted 1 August 2017; Published 22 October 2017

Academic Editor: Yudong Cai

Copyright © 2017 Jing-Wen Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Uddin, H. Yang, M. Shi, M. Polley-Mandal, and Z. Guo, “Elevation of oxidative stress in the aorta of genetically hypertensive mice,” Mechanisms of Ageing and Development, vol. 124, no. 7, pp. 811–817, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Giuseppe, L. Stéphane, A. R. Enrico et al., “Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document,” Journal of Hypertension, vol. 27, pp. 308–347, 2009. View at Google Scholar
  3. S. D. Pierdomenico, M. Di Nicola, A. L. Esposito et al., “Prognostic value of different indices of blood pressure variability in hypertensive patients,” American Journal of Hypertension, vol. 22, no. 8, pp. 842–847, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. L.-S. Liu, “Chinese guidelines for the management of hypertension,” Chinese Journal of Hypertension, vol. 39, no. 7, pp. 579–615, 2011. View at Google Scholar · View at Scopus
  5. M.-M. Wu, H. Sun, G.-X. He, T.-S. Wang, Z.-Q. Xiao, and X.-P. Feng, “Determination of differentially expressed proteins and it's significance among chronic sinusitis, nasal polyps and normal nasal mucosa,” Chinese Journal of Otorhinolaryngology Head and Neck Surgery, vol. 41, no. 3, pp. 171–175, 2006. View at Google Scholar · View at Scopus
  6. L. E. Hood, G. S. Omenn, R. L. Moritz et al., “New and improved proteomics technologies for understanding complex biological systems: addressing a grand challenge in the life sciences,” Proteomics, vol. 12, no. 18, pp. 2773–2783, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Tonack, M. Aspinall-O'Dea, R. E. Jenkins et al., “A technically detailed and pragmatic protocol for quantitative serum proteomics using iTRAQ,” Journal of Proteomics, vol. 73, no. 2, pp. 352–356, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Ray, P. J. Reddy, R. Jain, K. Gollapalli, A. Moiyadi, and S. Srivastava, “Proteomic technologies for the identification of disease biomarkers in serum: Advances and challenges ahead,” Proteomics, vol. 11, no. 11, pp. 2139–2161, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. L. V. DeSouza, J. Grigull, S. Ghanny et al., “Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry,” Molecular and Cellular Proteomics, vol. 6, no. 7, pp. 1170–1182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Ralhan, L. V. DeSouza, A. Matta et al., “Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry,” Molecular and Cellular Proteomics, vol. 7, no. 6, pp. 1162–1173, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Szklarczyk, A. Franceschini, M. Kuhn et al., “The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored,” Nucleic Acids Research, vol. 39, no. 1, pp. D561–D568, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. K. M. Redding, B. L. Chen, A. Singh et al., “Transgenic mice expressing an intracellular fluorescent fusion of angiotensin II demonstrate renal thrombotic microangiopathy and elevated blood pressure,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 298, no. 6, pp. H1807–H1818, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. L. V. Zelenchuk, A.-M. Hedge, and P. S. N. Rowe, “PHEX mimetic (SPR4-Peptide) corrects and improves HYP and wild type mice energy-metabolism,” PLoS ONE, vol. 9, no. 5, Article ID e97326, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Li, L. Nie, H. Jiang et al., “Metabonomics study of essential hypertension and its Chinese medicine subtypes by using gas chromatography-mass spectrometry and nuclear magnetic resonance spectroscopy,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 625906, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Katori and M. Majima, “The renal kallikrein-kinin system: its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension,” Critical Reviews in Clinical Laboratory Sciences, vol. 40, no. 1, pp. 43–115, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. A. L. Miranda-Vilela, A. K. Akimoto, P. C. Alves et al., “Evidence for an association between haptoglobin and MnSOD (Val9Ala) gene polymorphisms in essential hypertension based on a Brazilian case-control study.,” Genetics and molecular research : GMR, vol. 9, no. 4, pp. 2166–2175, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Balsa-Canto, J. R. Banga, J. A. Egea, A. Fernandez-Villaverde, and G. M. De Hijas-Liste, “Global optimization in systems biology: Stochastic methods and their applications,” Advances in Experimental Medicine and Biology, vol. 736, pp. 409–424, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. N. Song, G. B. Zhang, Y. Y. Zhang, and S. B. Su, “Clinical applications of omics technologies on ZHENG differentiation research in traditional Chinese medicine,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 989618, 11 pages, 2013. View at Publisher · View at Google Scholar
  19. M. G. Tonnesen, M. S. Klempner, K. F. Austen, and B. U. Wintroub, “Identification of a human neutrophil angiotensin II-generating protease as cathepsin G,” Journal of Clinical Investigation, vol. 69, no. 1, pp. 25–30, 1982. View at Publisher · View at Google Scholar · View at Scopus
  20. A. S. Brecher and R. Dubord, “Effect of acetaldehyde upon cathepsin G and chymase. NRAS implications,” Digestive Diseases and Sciences, vol. 53, no. 5, pp. 1311–1315, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Kurihara, M. Yoshizumi, T. Sugiyama et al., “Transforming growth factor-β stimulates the expression of endothelin mRNA by vascular endothelial cells,” Biochemical and Biophysical Research Communications, vol. 159, no. 3, pp. 1435–1440, 1989. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Kota, C. K. Hathaway, A. S. Chang, S. Oliver, and K. Masao, “Transforming growth factor beta1 and aldosterone,” Current Opinion in Nephrology and Hypertension, vol. 24, pp. 139–144, 2015. View at Google Scholar
  23. W. A. Border and N. A. Noble, “Interactions of transforming growth factor-β and angiotensin II in renal fibrosis,” Hypertension, vol. 31, no. 1, pp. 181–188, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Kagami, W. A. Border, D. E. Miller, and N. A. Noble, “Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells,” The Journal of Clinical Investigation, vol. 93, no. 6, pp. 2431–2437, 1994. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Yamada, C. H. Chue, N. Yukioka, and F. Hazama, “Causative role of lysosomal enzymes in the pathogenesis of cerebral lesions due to brain edema under chronic hypertension.,” Acta Neurochirurgica, Supplement, vol. 60, pp. 83–85, 1994. View at Google Scholar · View at Scopus
  26. L. Paczek, M. Teschner, R. M. Schaefer, J. Kovar, W. Romen, and A. Heidland, “Proteinase activity in isolated glomeruli of goldblatt hypertensive rats,” Clinical and Experimental Hypertension, vol. A13, no. 3, pp. 339–356, 1991. View at Publisher · View at Google Scholar · View at Scopus
  27. J. R. E. Fraser, T. C. Laurent, and U. B. G. Laurent, “Hyaluronan: its nature, distribution, functions and turnover,” Journal of Internal Medicine, vol. 242, no. 1, pp. 27–33, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. G. I. Frost, T. B. Csóka, T. Wong, and R. Stern, “Purification, cloning, and expression of human plasma hyaluronidase,” Biochemical and Biophysical Research Communications, vol. 236, no. 1, pp. 10–15, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. F. E. Lennon and P. A. Singleton, “Hyaluronan regulation of vascular integrity,” American Journal of Cardiovascular Disease, vol. 1, no. 3, pp. 200–213, 2011. View at Google Scholar
  30. M. Nieuwdorp, M. C. Meuwese, H. Vink, J. B. L. Hoekstra, J. J. P. Kastelein, and E. S. G. Stroes, “The endothelial glycocalyx: a potential barrier between health and vascular disease,” Current Opinion in Lipidology, vol. 16, no. 5, pp. 507–511, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Karadag, B. Ikitimur, H. Firinciogullari, H. A. Cakmak, K. Cosansu, and H. Yuksel, “The relationship between aortic stiffness and serum hyaluronidase levels in patients with diabetes mellitus and hypertension,” Blood Pressure, vol. 24, no. 1, pp. 35–40, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Scharfstein, V. Schmitz, E. Svensjö, A. Granato, and A. C. Monteiro, “Kininogens coordinate adaptive immunity through the proteolytic release of bradykinin, an endogenous danger signal driving dendritic cell maturation,” Scandinavian Journal of Immunology, vol. 66, no. 2-3, pp. 128–136, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. R. W. Colman, A. Bagdasarian, R. C. Talamo et al., “Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor dependent pathways,” Journal of Clinical Investigation, vol. 56, no. 6, pp. 1650–1662, 1975. View at Publisher · View at Google Scholar · View at Scopus
  34. G. A. Iarovaia, “Kallikrein-kinin system: novel facts and concepts (literature review),” Voprosy Meditsinskoi Khimii, vol. 47, pp. 20–42, 2001. View at Google Scholar
  35. M. V. Paul, Z. Yingzi, X. Aimin, and W. S. L. Susan, “Thirty years of saying no sources, fate, actions, and misfortunes of the endothelium-derived vasodilator mediator,” Circulation Research, vol. 119, no. 2, pp. 375–96, 2016. View at Google Scholar